Private Equity
Venture capitalists poured more money into Internet and software startups last year than they have since the height of the dot-com boom in 2000.
2 min read · 16 January 2015
The Canadian firm has secured C$134 million (US$112 million) in an initial close to invest in biotherapeutics and other life sciences
3 min read · 15 January 2015
Boston-based HarbourVest Partners is expected to complete an initial close on a new Canadian venture fund of funds before the end of January, said three people with knowledge of the matter.
3 min read · 15 January 2015
AC JumpStart, an incubation and mentorship program targeted to technology startups in Southwestern Ontario, has been launched with $8 million in funding from the Federal Economic Development Agency for Southern Ontario (FedDev Ontario). The program, which is managed by Waterloo commercialization hub Accelerator Centre, will provide $30,000 in seed capital to qualifying companies. It is expected that 180 companies will participate in the program over the next four years.
4 min read · 15 January 2015
DBL Investors has raised a $356.4 million third fund, according to a filing with the Securities and Exchange Commission. Listed as directors of the fund are firm founder Nancy Pfund and Ira Ehrenpreis.
1 min read · 15 January 2015
Felicis Ventures has expanded the size of its fourth fund to $120.6 million from 96.4 million, according to a filing with the Securities and Exchange Commission. The expansion coincides with the addition of Wesley Chan as a new managing partner at the firm.
1 min read · 15 January 2015
Teralys Capital has committed $50 million to the first close of CTI II, the second life sciences fund of Canadian venture capital firm CTI Life Sciences. As reported by peHUB Canada, the firm raised $134 million of a targeted $150 million for its fund. Other investors in CTI II included the Caisse de dépôt et placement du Québec, Fonds de solidarité FTQ and BDC Capital. The Montréal-based Teralys last November secured $279 million in the initial close of its second investment vehicle, Teralys Capital Innovation Fund.
3 min read · 15 January 2015
Canadian venture capital firm CTI Life Sciences has secured $134 million in the initial close of its second partnership, CTI II, earmarked for investments in biotherapeutics and other life sciences companies. The result puts CTI II within reach of the $150 million target set for the fund, which is expected to wrap up by mid-2015, said Ken Pastor, co-founder and general partner of the Montréal-based firm.
3 min read · 15 January 2015
Montreal-based CTI Life Sciences has raised C$134 million in the first close of its second venture fund. The pool's limited partners include Teralys Capital and BDC Capital via the Government of Canada's Venture Capital Action Plan. CTI II will invest mostly in biotherapeutics.
3 min read · 15 January 2015
TVC Capital has closed its oversubscribed third fund at $115 million. The pool's limited partners include fund of funds managers and a university endowment. TVC Capital III will focus on making investments in software firms that are generating over $2.5 million in revenue.
3 min read · 15 January 2015
